Pralatrexate (52853-40-4)
Specifications
CAS:
52853-40-4
Specification:
CP, EP, In-house, As Required
M.F.:
C23H23N7O5
M.W.:
477.47
Assay:
98%
Shelf Life:
2 Years
Package:
25kg/drum
Highlight:
Pralatrexate 52853-40-4
,anti tumor pralatrexate t cell lymphoma
,CAS: 52853-40-4 pralatrexate t cell lymphoma
Introduction
Pralatrexate, an injectable DHFR inhibitor, was launched for the treatment of patients with relapsed or refractory PTCL. The inhibition of the folate enzymes DHFR and thymidylate synthase is a well-validated method of cancer treatment.
Product Name: | Pralatrexate |
CAS No.: | 52853-40-4 |
Assay: | 989% |
Specification: | CP, EP, In-house, as required |
Molecular Formula: | C23H23N7O5 |
Molecular Weight: | 477.47 |
Shelf Life: | 2 Years |
Package: | 25kg/drum |
Related Products
Image | Part # | Description | |
---|---|---|---|
![]() |
6-(Bromomethyl)-2,4-pteridinediamine hydrobromide (52853-40-4) |
CAS: 52853-40-4; anti-tumor ; pralatrexate t cell lymphoma; intermediate
|
Send RFQ
Stock:
In Stock
MOQ: